PRISMAP: A European network for medical radioisotope production and research

Fri, Oct 1, 2021, 5:00PMNuclear News
A conceptual image of collaboration across Europe. (Image: PRISMAP/SCIPROM)

Only a few of the more than 3,000 radioisotopes that scientists have synthesized in the laboratory are regularly used in diagnostic or therapeutic medicine. One significant barrier to the development of new medical radioisotopes is the difficulty of gaining access to radionuclides during the early stages of development and research. PRISMAP is a new medical radionuclide program designed to streamline that access for medical research in the European Union and the United Kingdom.

To continue reading, log in or create a free account!

Related Articles

Investors line up for Sizewell C

Thu, Jul 10, 2025, 5:01PMNuclear News

As the U.K. government looks to finalize investment decisions for the construction of the Sizewell C nuclear power plant this summer, France’s state-owned EDF has announced plans to take a...